BioLife Solutions, Inc., a supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, announced that all of its SciSafe-branded biostorage facilities in the USA have been accredited by the College of American Pathologists (CAP).
The CAP Laboratory Accreditation is awarded to laboratories that meet very stringent requirements and maintain the highest standard of quality, accuracy, and consistency, considered equal to or more rigorous than the U.S. federal government's inspection program.
"All SciSafe facilities in the U.S. have earned the prestigious CAP-BAP accreditation, demonstrating our continual commitment to our mission of providing superior quality biostorage services," said Karen Foster, Global Chief Quality Officer at BioLife Solutions.
SciSafe Biostorage Centers of Excellence are now compliant to the following standards:
- ISO 9001
-
ISO 20387
-
cGMP FDA compliant
-
FDA registered and inspected since 2011 (CDER and CBER)
-
GDP (Good Distribution Practice)
-
CAP-BAP accredited in US facilities as of 2023
